Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor

Plastic and Reconstructive Surgery

Volumn 97, Issue 3, 1996, Pages 587-594

  Lantieri, Laurent A ^a   Ozbek, Mustafa R ^a   Deune, E Gene ^a   Ornberg, Richard L ^a   Brown, David M ^a   Chung, S H ^a   Wun, Tze Chein ^a   Cooley, Brian C ^a   Khouri, Roger K ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRUDIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HEPARIN; HIRUDINS; LIPOPROTEINS; MICROCIRCULATION; RABBITS; RECOMBINANT PROTEINS; THROMBOSIS; VASCULAR PATENCY;

EID: 0030027273     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199603000-00015     Document Type: Article

References (44)

1. Wessler, S., and Gitel, S. N. Thrombosis: The relationship of hemostatic mechanisms to drug therapy. J. Neurosurg. 54: 1, 1981.
2. Verstraete, M., Dejana, E., Fuster, V., Lapetina, E., Moncada, S., Mustard, J. F., Tans, G., and Vargaftig, B. B. An overview of antiplatelet and antithrombotic drugs. Haemostasis 15: 89, 1985.
3. Hirsh, J. Effectiveness of anticoagulants. Semin. Thromb. Hemost. 12: 21, 1986.
4. Fukui, A., Maeda, M., Sempuku, T., Tamai, S., Mizumoto, S., and Inada, Y. Continuous local intra-arterial infusion of anticoagulants for digit replantation and treatment of damaged arteries. J. Reconstr. Microsurg. 5: 127, 1989.
5. Jelalian, C., Mehrhof, A., Cohen, I. K., Richardson, J., and Merritt, W. H. Streptokinase in the treatment of acute arterial occlusion of the hand. J. Hand Surg. 10A: 534, 1985.
6. Schubert, W., Hunter, D. W., Guzman-Stein, G., Ahrenholz, D. H., Solem, L. D., Dressel, T. D., and Cunningham, B. L. Use of streptokinase for the salvage of a free flap: Case report and review of the use of thrombolytic therapy. Microsurgery 8: 117, 1987.
7. Khouri, R. K., Koudsi, B., Kaiding, F., Ornberg, R. L., and Wun, T. C. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma. Ann. Plast. Surg. 30: 398, 1993.
8. Broze, G. J., Jr., Girard, T. J., and Novotny, W. F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 29: 7539, 1990.
9. Rapaport, S. I. Inhibition of factor VIIa/tissue factor-induced blood coagulation: With particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood 73: 359, 1989.
10. Broze, G. J., Jr., Warren, L. A., Novotny, W. F., Higuchi, D. A., Girard, J. J., and Miletich, J. P. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 71: 335, 1988.
11. Cooley, B. C., Hanel, D. P., Gould, J. S., Li, X. L., and Smith, J. W. Antithrombotic benefit of topically applied subendothelium-bound urokinase: An experimental study. J. Hand Surg. 17A: 235, 1992.
12. Ozbek, M. R., Deune, E. G., Cooley, B. C., and Khouri, R. K. Experimental reproduction of free flap errors: A new model of thrombosis. Ann. Plast. Surg. 32: 474, 1994.
13. Diaz-Collier, J. A., Palmier, M. O., Kretzmer, K. K., Bishop, B. F., Combs, R. G., Frazier, R. B., Bild, G. S., Joy, W. D., Hill, S. R., and Duffin, K. L. Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli. Thromb. Haemost. 71: 339, 1994.
14. Ornberg, R. L., Deune, E. G., Ozbek, M. R., Wun, T.-C., and Khouri, R. K. Localization of TFPI binding sites in an intimectomized microvessel. Thromb. Haemost. 73: 55, 1995.
15. Houdijk, W. P. M., Sakariassen, K. S., Nievelstein, P. F. E. M., and Sixma, J. J. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J. Clin. Invest. 75: 531, 1985.
16. Sakariassen, K. S., Muggli, R., and Baumgartner, H. R. Measurements of platelet interaction with components of the vessel wall in flowing blood. Methods Enzymol. 169: 37, 1989.
17. Gu, J. M., Acland, R. D., Anderson, G. L., Wyllie, F., and Barker, J. H. Poor surgical technique produces more emboli after arterial anastomosis of an island flap. Br. J. Plast. Surg. 44: 126, 1991.
18. Ryan, J., Brett, J., Tijburg, P., Bach, R. R., Kisiel, W., and Stern, D. Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood 80: 966, 1992.
19. Wilcox, J. N., Smith, K. M., Schwartz, S. M., and Gordon, D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. U.S.A. 86: 2839, 1989.
20. Khouri, R. K., Cooley, B. C., Kenna, D. M., and Edstrom, L. Thrombosis of microvascular anastomoses in traumatized vessels: Fibrin versus platelets. Plast. Reconstr. Surg. 86: 110, 1990.
21. Broze, G. J., Jr., Girard, T. J., and Novotny, W. F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 29: 7539, 1990.
22. Rao, L. V. M., and Rapaport, S. I. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 69: 645, 1987.
23. a binding site on platelets. J. Biol. Chem. 253: 6908, 1978.
24. Eisenberg, P. R., Siegel, J. E., Abendschein, D. R., and Miletich, J. P. Importance of factor Xa in determining the procoagulant activity of whole blood clots. J. Clin. Invest. 91: 1877, 1993.
25. Chesebro, J. H., Zoldhelyi, P., Badimon, L., and Fuster, V. Role of thrombin in arterial thrombosis: Implications for therapy. Thromb. Haemost. 66: 1, 1991.
26. Hatton, M. W. C., and Moar, S. L. Comparison of the effects of heparin and hirudin on thrombin binding to the normal and the deendothelialized rabbit aorta in vitro. Thromb. Haemost. 66: 208, 1991.
27. Donayre, C. E., Ouriel, K., Rhee, R. Y., and Shortell, C. K. Future alternatives to heparin: Low-molecular-weight heparin and hirudin. J. Vasc. Surg. 15: 675, 1992.
28. Lesnik, P., Vonica, A., Guerin, M., Moreau, M., and Chapman, M. J. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscler. Thromb. 13: 1066, 1993.
29. Palmier, M. O., Hall, L. J., Reisch, C. M., Baldwin, M. K., Wilson, A. G. E., and Wun, T.-C. Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbits. Thromb. Haemost. 68: 33, 1992.
30. Hiebert, L. M., and Jaques, L. B. The observation of heparin on endothelium after injection. Thromb. Res. 8: 195, 1976.
31. Hiebert, L. M., and Jaques, L. B. Heparin uptake on endothelium. Artery 2: 26, 1976.
32. Mahadoo, J., Hiebert, L., and Jaques, L. B. Vascular sequestration of heparin. Thromb. Res. 12: 79, 1977.
33. Glimelius, B., Busch, C., and Hook, M. Binding of heparin on the surface of cultured human endothelial cells. Thromb. Res. 12: 773, 1978.
34. Reichel, C. A., Croll, G. H., and Puckett, C. L. A comparison of irrigation solutions for microanastomoses. J. Hand Surg. 13A: 33, 1988.
35. Sinclair, S. The importance of topical heparin in microvascular anastomoses: A study in the rat. Br. J. Plast. Surg. 33: 422, 1980.
36. Cox, G. W., Runnels, S., Hsu, H. S. H., and Das, S. K. A comparison of heparinised saline irrigation solutions in a model of microvascular thrombosis. Br. J. Plast. Surg. 45: 345, 1992.
37. Braam, M. J., Cooley, B. C., and Gould, J. S. Topical heparin enhances patency in a rat model of arterial thrombosis. Ann. Plast. Surg. (in press).
38. Wieslander, J. B., and Dougan, P. Washout of vessels with heparin does not improve patency following severe microarterial trauma: An experimental study. Ann. Plast. Surg. 24: 216, 1990.
39. Cooley, B. C., Dollinger, B. M., Mlsna, J. S., and Gould, J. S. Maintenance of patency following vascular trauma by topical irrigation with peptide homologous to the carboxy-terminus of the fibrinogen gamma-chain. J. Hand Surg. 17A: 1044, 1992.
40. Kloczewiak, M., Timmons, S., and Hawiger, J. Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. Biochem. Biophys. Res. Commun. 107: 181, 1982.
41. Farrell, D. H., Thiagarajan, P., Chung, D. W., and Davie, E. W. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc. Natl. Acad. Sci. U.S.A. 89: 10729, 1992.
42. Hettasch, J. M., Bolyard, M. G., and Lord, S. T. The residues AGDV of recombinant gamma chains of human fibrinogen must be carboxy-terminal to support human platelet aggregation. Thromb. Haemost. 68: 701, 1992.
43. Doolittle, R. F., Cassman, K. G., Chen, R., Sharp, J. J., and Wooding, G. L. Correlation of the mode of fibrin polymerization with the pattern of cross-linking. Ann. N.Y. Acad. Sci. 202: 114, 1972.
44. Khouri, R. K. Avoiding free flap failure. Clin. Plast. Surg. 19: 773, 1992.